The store will not work correctly when cookies are disabled.
1-((4-Methoxyphenyl)sulfonyl)-3-(4-(trifluoromethyl)phenyl)-imidazolidin-2-one
ID: ALA4208156
Chembl Id: CHEMBL4208156
PubChem CID: 137443819
Max Phase: Preclinical
Molecular Formula: C17H15F3N2O4S
Molecular Weight: 400.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(S(=O)(=O)N2CCN(c3ccc(C(F)(F)F)cc3)C2=O)cc1
Standard InChI: InChI=1S/C17H15F3N2O4S/c1-26-14-6-8-15(9-7-14)27(24,25)22-11-10-21(16(22)23)13-4-2-12(3-5-13)17(18,19)20/h2-9H,10-11H2,1H3
Standard InChI Key: ZDQVKDVGARGGFQ-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 400.38 | Molecular Weight (Monoisotopic): 400.0705 | AlogP: 3.34 | #Rotatable Bonds: 4 |
Polar Surface Area: 66.92 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.11 | CX LogD: 3.11 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.79 | Np Likeness Score: -1.62 |
References
1. Xu Q, Kulkarni AA, Sajith AM, Hussein D, Brown D, Güner OF, Reddy MD, Watkins EB, Lassègue B, Griendling KK, Bowen JP.. (2018) Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4., 26 (5): [PMID:29426628] [10.1016/j.bmc.2017.12.023] |